Supporting the significance of the NLRP3 inflammasome in the pathogenesis of RA and its comorbidities, increasing clinical and pre-clinical evidence has revealed the components of the NLRP3 inflammasome as potential therapeutic targets in RA [43,52,53,54]. Here, NLRP3 is linked to rheumatoid arthritis.